Bryan Ellertson
Pediatrics · Layton, UTNPI 1881989143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $476 and has fallen 73.2% since, to $127 in 2025. Among pediatrics clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$311
- Boehringer Ingelheim$248
- Takeda Pharmaceuticals U.S.A., Inc.$140
- Amgen$136
- Cranial Technologies, Inc$86
- Dynavax Technologies Corporation$80
- plus $917 from 30 others
What the payments were for
- Food & beverage$1,918100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 21 | $311 |
| Boehringer Ingelheim | 13 | $248 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $140 |
| Amgen | 9 | $136 |
| Cranial Technologies, Inc | 5 | $86 |
| Dynavax Technologies Corporation | 5 | $80 |
| Lilly USA, LLC | 6 | $79 |
| Johnson & Johnson(2 entities) | 5 | $78 |
| Merck | 4 | $71 |
| Pfizer | 5 | $64 |
| Amarin Pharma, Inc. | 4 | $56 |
| Kyowa Kirin, Inc. | 3 | $54 |
| Tris Pharma Inc | 3 | $52 |
| Smith+Nephew | 1 | $51 |
| Shire North American Group Inc | 3 | $41 |
| Shield Therapeutics Inc | 2 | $32 |
| Upsher-smith Laboratories LLC | 2 | $29 |
| Novo Nordisk | 2 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Organon | 2 | $16 |
| AstraZeneca | 1 | $16 |
| AbbVie | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Halozyme Inc | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Seqirus USA Inc | 1 | $12 |
| Bioventus LLC | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$1,918 in reported general payments places this provider in the 90th percentile of 439 pediatrics providers in Utah.
Other pediatrics in Layton
- Mari LuceLayton$289K
- Michael HussemanLayton$4K
- Noel NyeLayton$3K
- Nathan ForbushLayton$3K
- Ryan EvansLayton$3K
- Brent EberhardLayton$2K
- Jason HoaglandLayton$2K
- Robert HokiLayton$2K
- Colton RagsdaleLayton$2K
- David NuttallAmerican Fork$307K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.